AFT Pharmaceuticals raises $9.1M via redeemable share issue, announces SPP

AFT Pharmaceuticals raises $9.1M via redeemable share issue, announces SPP
Rebecca Howard
By Rebecca Howard March 17 (BusinessDesk) -  AFT Pharmaceuticals, which manufactures the Maxigesic painkiller, raised new funds through a redeemable share issue to fuel international growth and announced plans to raise more capital in a share purchase plan. The Auckland-based drug maker said the redeemable share issue raised approximately $9.1 million from CRG, a US health-care investor, and the Atkinson Family Trust at $2.74 per share, equal to the volume weighted average price of AFT's ordinary shares on the NZX over the last five busin...